ASTH Astrana Health Inc.
Price (delayed)
$31.14
Market cap
$1.75B
P/E Ratio
34.22
Dividend/share
N/A
EPS
$0.91
Enterprise value
$1.94B
apollo medical holdings, inc., a physician-centric technology-powered healthcare management company, provides medical care services. the company, leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based
Highlights
The revenue is up by 47% year-on-year and by 18% since the previous quarter
ASTH's gross profit is up by 26% year-on-year and by 4.4% since the previous quarter
The price to earnings (P/E) is 3.9% higher than the 5-year quarterly average of 32.7 but 2.1% lower than the last 4 quarters average of 34.7
The debt has increased by 47% year-on-year
Astrana Health's net income has decreased by 31% QoQ and by 29% YoY
Key stats
What are the main financial stats of ASTH
Market
Valuations
Earnings
Shares outstanding
56.25M
Market cap
$1.75B
Enterprise value
$1.94B
Price to earnings (P/E)
34.22
Price to book (P/B)
2.46
Price to sales (P/S)
0.86
EV/EBIT
18.06
EV/EBITDA
13.79
EV/Sales
0.95
Revenue
$2.03B
Gross profit
$271.39M
Operating income
$89.35M
Net income
$43.15M
EBIT
$107.13M
EBITDA
$140.34M
Free cash flow
$44.17M
Per share
Balance sheet
Liquidity
EPS
$0.91
EPS diluted
$0.9
Free cash flow per share
$0.79
Book value per share
$12.67
Revenue per share
$36.17
TBVPS
$14.53
Total assets
$1.35B
Total liabilities
$840.73M
Debt
$471.84M
Equity
$712.72M
Working capital
$272.89M
Debt to equity
0.66
Current ratio
1.75
Quick ratio
1.63
Net debt/EBITDA
1.31
Margins
Efficiency
Dividend
EBITDA margin
6.9%
Gross margin
13.3%
Net margin
2.1%
Operating margin
4.4%
Return on assets
3.4%
Return on equity
6.3%
Return on invested capital
19.3%
Return on capital employed
10.8%
Return on sales
5.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ASTH stock price
How has the Astrana Health stock price performed over time
Intraday
0.78%
1 week
-0.76%
1 month
-2.35%
1 year
-15.86%
YTD
-1.24%
QTD
0.42%
Financial performance
How have Astrana Health's revenue and profit performed over time
Revenue
$2.03B
Gross profit
$271.39M
Operating income
$89.35M
Net income
$43.15M
Gross margin
13.3%
Net margin
2.1%
The net margin has dropped by 52% year-on-year and by 42% since the previous quarter
The revenue is up by 47% year-on-year and by 18% since the previous quarter
Astrana Health's net income has decreased by 31% QoQ and by 29% YoY
The company's operating margin fell by 28% YoY and by 10% QoQ
Growth
What is Astrana Health's growth rate over time
Valuation
What is Astrana Health stock price valuation
P/E
34.22
P/B
2.46
P/S
0.86
EV/EBIT
18.06
EV/EBITDA
13.79
EV/Sales
0.95
The EPS has declined by 31% since the previous quarter and by 30% year-on-year
The price to earnings (P/E) is 3.9% higher than the 5-year quarterly average of 32.7 but 2.1% lower than the last 4 quarters average of 34.7
ASTH's price to book (P/B) is 49% lower than its 5-year quarterly average of 4.8 and 30% lower than its last 4 quarters average of 3.5
Astrana Health's equity has increased by 16% YoY
ASTH's P/S is 63% below its 5-year quarterly average of 2.3 and 39% below its last 4 quarters average of 1.4
The revenue is up by 47% year-on-year and by 18% since the previous quarter
Efficiency
How efficient is Astrana Health business performance
Astrana Health's return on assets has decreased by 43% YoY and by 36% QoQ
Astrana Health's return on equity has decreased by 40% YoY and by 33% QoQ
The return on sales has declined by 32% year-on-year and by 23% since the previous quarter
The company's return on invested capital fell by 23% YoY and by 20% QoQ
Dividends
What is ASTH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ASTH.
Financial health
How did Astrana Health financials performed over time
The total assets is 61% more than the total liabilities
The company's total liabilities has surged by 61% YoY and by 8% QoQ
The total assets has grown by 45% YoY and by 5% from the previous quarter
The debt is 34% smaller than the equity
The debt has increased by 47% year-on-year
The company's debt to equity rose by 27% YoY but it fell by 2.9% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.